Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2012 May;55(5):1255-62.
doi: 10.1016/j.jvs.2011.11.063. Epub 2012 Jan 23.

Retrograde ascending aortic dissection as an early complication of thoracic endovascular aortic repair

Affiliations

Retrograde ascending aortic dissection as an early complication of thoracic endovascular aortic repair

Judson B Williams et al. J Vasc Surg. 2012 May.

Abstract

Objective: Retrograde ascending aortic dissection (rAAD) is a potential complication of thoracic endovascular aortic repair (TEVAR), yet little data exist regarding its occurrence. This study examines the incidence, etiology, and outcome of this event.

Methods: A prospective institutional database was used to identify cases of acute rAAD following TEVAR from a cohort of 309 consecutive procedures from March 2005 (date of initial Food and Drug Administration approval) to September 2010. The database was analyzed for the complication of rAAD as well as relevant patient and operative variables.

Results: The incidence of rAAD was 1.9% (6/309); all cases occurred with proximal landing zone in the ascending aorta and/or arch (zones 0-2). All were identified in the perioperative period (range, 0-6 days) with 33% (2/6) 30-day/in-hospital mortality. Eighty-three percent (5/6) underwent emergent repair; one patient died without repair. rAAD patients were similar to the non-rAAD group (n = 303) across pertinent variables, including age, gender, race, and device size (all P > .1). rAAD incidence by aortic pathology was 1.0% (2/200) for aneurysm, 4.4% (4/91) for dissection, and 0% (0/18) for transection; P = .08. rAAD incidence by device was TAG (Gore) 1.0% (2/205), Talent (Medtronic) 4.7% (2/43), and Zenith TX2 (Cook) 3.6% (2/55). rAAD incidence was observed to be higher among patients with an ascending aortic diameter ≥ 4.0 cm (4.8% vs 0.9% for ascending diameter <4.0 cm); P = .047. Incidence was also higher with proximal landing zone in the native ascending aorta (zone 0) 6.9% (2/29) versus 1.4% for all others (4/280); P = .101. For patients with dissection pathology and an ascending aortic diameter ≥ 4.0 cm, 11% (3/28) suffered rAAD; with the combination of native ascending aorta (zone 0) landing zone measuring ≥ 4.0 cm, the incidence was 25% (2/8). Definitive diagnosis was by computed tomography angiography (n = 1), intraoperative transesophageal echocardiography (n = 3), intraoperative arteriography (n = 1), or postmortem autopsy (n = 1).

Conclusions: rAAD is a lethal early complication of TEVAR, which may be more common when treating dissection, with devices utilizing proximal bare springs or barbs for fixation, with native zone 0 proximal landing zone and with ascending aortic diameter ≥ 4 cm. Combinations of these risk factors may be particularly high risk. Intraoperative imaging assessment of the ascending aorta should be conducted following TEVAR to avoid under-recognition. National database reporting of this complication is needed to ensure safety and proper application of emerging TEVAR technology.

PubMed Disclaimer

Conflict of interest statement

Competition of interest: Medtronic Vascular: consultant, speaker (GCH); W.L. Gore and Associates: consultant, speaker, unrestricted research grant (GCH); Vascutek Terumo: consultant, speaker (GCH, RLM)

Figures

Figure 1
Figure 1
Preoperative computed tomography angiography (CTA) in patient undergoing thoracic endografting (TEVAR) for chronic Type B dissection with aneurysm who suffered postoperative retrograde ascending aortic dissection (rAAD). Note dilated ascending aorta measuring 4.5 cm (A); Normal transesophageal echocardiogram (TEE) at the completion of TEVAR procedure (B); CTA obtained after new onset chest pain and hypotension on postoperative day 6 revealing acute rAAD (C); Intraoperative TEE showing retrograde ascending aortic dissection at the time of open repair (D)
Figure 1
Figure 1
Preoperative computed tomography angiography (CTA) in patient undergoing thoracic endografting (TEVAR) for chronic Type B dissection with aneurysm who suffered postoperative retrograde ascending aortic dissection (rAAD). Note dilated ascending aorta measuring 4.5 cm (A); Normal transesophageal echocardiogram (TEE) at the completion of TEVAR procedure (B); CTA obtained after new onset chest pain and hypotension on postoperative day 6 revealing acute rAAD (C); Intraoperative TEE showing retrograde ascending aortic dissection at the time of open repair (D)
Figure 1
Figure 1
Preoperative computed tomography angiography (CTA) in patient undergoing thoracic endografting (TEVAR) for chronic Type B dissection with aneurysm who suffered postoperative retrograde ascending aortic dissection (rAAD). Note dilated ascending aorta measuring 4.5 cm (A); Normal transesophageal echocardiogram (TEE) at the completion of TEVAR procedure (B); CTA obtained after new onset chest pain and hypotension on postoperative day 6 revealing acute rAAD (C); Intraoperative TEE showing retrograde ascending aortic dissection at the time of open repair (D)
Figure 1
Figure 1
Preoperative computed tomography angiography (CTA) in patient undergoing thoracic endografting (TEVAR) for chronic Type B dissection with aneurysm who suffered postoperative retrograde ascending aortic dissection (rAAD). Note dilated ascending aorta measuring 4.5 cm (A); Normal transesophageal echocardiogram (TEE) at the completion of TEVAR procedure (B); CTA obtained after new onset chest pain and hypotension on postoperative day 6 revealing acute rAAD (C); Intraoperative TEE showing retrograde ascending aortic dissection at the time of open repair (D)

References

    1. Nienaber C, Fattori R, Lund G, Dieckmann C, Wolf W, von Kodolitsch Y, Nicolas V, Pierangeli A. Nonsurgical reconstruction of thoracic aortic dissection by stent-graft placement. N Engl J Med. 1999;(340):1539–45. - PubMed
    1. Hughes G, Lee SM, Daneshmand MA, Bhattacharya SD, Williams JB, Tucker SW, Jr, McCann RL. Endovascular repair of descending thoracic aneurysms: results with “on-label” application in the post Food and Drug Administration approval era. Ann Thorac Surg. 2010;90(1):83–9. - PMC - PubMed
    1. Dake M, Miller DC, Semba CP, Mitchell RS, Walker PJ, Liddell RP. Transluminal placement of endovascular stent-grafts for the treatment of descending thoracic aortic aneurysms. N Engl J Med. 1994;331(26):1729–34. - PubMed
    1. Cho J, Haider SE, Makaroun MS. Endovascular therapy of thoracic aneurysms: Gore TAG trial results. Semin Vasc Surg. 2006;19(1):1–24. - PubMed
    1. Behrman RE, Benner JS, Brown JS, McClellan M, Woodcock J, Platt R. Developing the Sentinel System--a national resource for evidence development. N Engl J Med. 2011;364(6):498–9. - PubMed

Publication types

MeSH terms